183 related articles for article (PubMed ID: 26288134)
1. N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production.
Chang MC; Wu JY; Liao HF; Chen YJ; Kuo CD
Anticancer Drugs; 2015 Nov; 26(10):1034-42. PubMed ID: 26288134
[TBL] [Abstract][Full Text] [Related]
2. Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production.
Liao HF; Chen YJ; Chou CH; Wang FW; Kuo CD
Toxicol In Vitro; 2011 Feb; 25(1):206-12. PubMed ID: 21075198
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: A quantitative pilot study.
Chang MC; Wu JY; Liao HF; Chen YJ; Kuo CD
Medicine (Baltimore); 2016 Aug; 95(31):e4467. PubMed ID: 27495082
[TBL] [Abstract][Full Text] [Related]
4. N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model.
Chang MC; Tsai ET; Wu JY; Liao HF; Chen YJ; Kuo CD
Anticancer Drugs; 2015 Jun; 26(5):508-17. PubMed ID: 25588161
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
[TBL] [Abstract][Full Text] [Related]
6. Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells.
Liao HF; Su SL; Chen YJ; Chou CH; Kuo CD
Food Chem Toxicol; 2007 Sep; 45(9):1678-87. PubMed ID: 17442474
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of cytokine production and AP-1 transcriptional activity in T cells by thalidomide-related immunomodulatory drugs.
Schafer PH; Gandhi AK; Loveland MA; Chen RS; Man HW; Schnetkamp PP; Wolbring G; Govinda S; Corral LG; Payvandi F; Muller GW; Stirling DI
J Pharmacol Exp Ther; 2003 Jun; 305(3):1222-32. PubMed ID: 12649301
[TBL] [Abstract][Full Text] [Related]
8. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
Ahn CH; Hong KO; Jin B; Lee W; Jung YC; Lee H; Shin JA; Cho SD; Hong SD
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31315217
[TBL] [Abstract][Full Text] [Related]
9. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
[TBL] [Abstract][Full Text] [Related]
10. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members.
Surapisitchat J; Hoefen RJ; Pi X; Yoshizumi M; Yan C; Berk BC
Proc Natl Acad Sci U S A; 2001 May; 98(11):6476-81. PubMed ID: 11353829
[TBL] [Abstract][Full Text] [Related]
11. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells.
Chen YN; Cheng CC; Chen JC; Tsauer W; Hsu SL
Br J Pharmacol; 2003 Oct; 140(3):461-70. PubMed ID: 12970086
[TBL] [Abstract][Full Text] [Related]
12. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase-dependent apoptosis in norcan-tharidin-treated A375-S2 cells is proceeded by the activation of protein kinase C.
An WW; Wang MW; Tashiro S; Onodera S; Ikejima T
Chin Med J (Engl); 2005 Feb; 118(3):198-203. PubMed ID: 15740647
[TBL] [Abstract][Full Text] [Related]
14. Effects of silver nanoparticles and gold nanoparticles on IL-2, IL-6, and TNF-α production via MAPK pathway in leukemic cell lines.
Parnsamut C; Brimson S
Genet Mol Res; 2015 Apr; 14(2):3650-68. PubMed ID: 25966134
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
[TBL] [Abstract][Full Text] [Related]
16. Extracellular signal regulated protein kinase and c-jun N-terminal kinase are involved in ml muscarinic receptor-enhanced interleukin-2 production pathway in Jurkat cells.
Fujino H; Uehara T; Murayama T; Okuma Y; Ariga H; Nomura Y
Biol Pharm Bull; 2000 Oct; 23(10):1198-205. PubMed ID: 11041251
[TBL] [Abstract][Full Text] [Related]
17. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
[TBL] [Abstract][Full Text] [Related]
18. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
19. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
20. p38-NF-κB-promoted mitochondria-associated apoptosis and G2/M cell cycle arrest in norcantharidin-treated HeLa cells.
Dong X; Li JC; Jiang YY; Xia MY; Tashiro S; Onodera S; Ikejima T
J Asian Nat Prod Res; 2012; 14(11):1008-19. PubMed ID: 23281704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
